Intracellular hydrogelation of macrophage conjugated probiotics for hitchhiking delivery and combined treatment of colitis

Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease

(2023) Mingyi Li et al.   Bioactive Materials

Macrophages disseminate pathogen associated molecular patterns through the direct extracellular release of the soluble content of their phagolysosomes

(2022) Catherine J. Greene et al.   Nature Communications

Bionic Regulators Break the Ecological Niche of Pathogenic Bacteria for Modulating Dysregulated Microbiome in Colitis

(2022) Jiali Yang et al.   ADVANCED MATERIALS

Mannose ameliorates experimental colitis by protecting intestinal barrier integrity

(2022) Lijun Dong et al.   Nature Communications

Decorated bacteria and the application in drug delivery

(2022) Feng Wu et al.   ADVANCED DRUG DELIVERY REVIEWS

Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism

(2022) Peter Spanogiannopoulos et al.   Nature Microbiology

Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease

(2022) Yuji Pu et al.   JOURNAL OF CONTROLLED RELEASE

Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases

(2022) Jun Liu et al.   Science Advances

Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut

(2021) Mousumi Mahapatro et al.   Cells

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

(2021) James L Alexander et al.   Lancet Gastroenterology & Hepatology

Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy

(2021) Runqi Zhu et al.   Advanced Science

Mucosal immunity–mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer’s patches

(2021) Sisi Lin et al.   Science Advances

Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis

(2021) Qiaoyan Liu et al.   GUT

Colonic mucus-accumulating tungsten oxide nanoparticles improve the colitis therapy by targeting Enterobacteriaceae

(2021) Yuting Qin et al.   Nano Today

The promise of the gut microbiome as part of individualized treatment strategies

(2021) Daniel A. Schupack et al.   Nature Reviews Gastroenterology & Hepatology

Matrix lumican endocytosed by immune cells controls receptor ligand trafficking to promote TLR4 and restrict TLR9 in sepsis

(2021) George Maiti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Analyzing the synergistic adverse effects of BPA and its substitute, BHPF, on ulcerative colitis through comparative metabolomics

(2021) Feiying Yin et al.   CHEMOSPHERE

Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier–Dependent Manner

(2021) Ruige Cao et al.   MOLECULES

Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study

(2021) Severine Vermeire et al.   Lancet Gastroenterology & Hepatology

The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial

(2021) Henit Yanai et al.   Lancet Gastroenterology & Hepatology

Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells

(2020) Nick Powell et al.   GUT

Glucocorticoid-Induced Leucine Zipper as a Druggable Target in Inflammatory Bowel Diseases

(2020) Simona Ronchetti et al.   INFLAMMATORY BOWEL DISEASES

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

(2020) Aonghus Lavelle et al.   Nature Reviews Gastroenterology & Hepatology

Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD

(2020) Irma Tindemans et al.   Cells

Novel Metal–Organic Framework-Based Photocrosslinked Hydrogel System for Efficient Antibacterial Applications

(2020) Kihak Gwon et al.   ACS Applied Materials & Interfaces

Recent Advances of Cell Membrane‐Coated Nanomaterials for Biomedical Applications

(2020) Wen‐Long Liu et al.   ADVANCED FUNCTIONAL MATERIALS

Engineered Cell‐Membrane‐Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity

(2020) Yao Jiang et al.   ADVANCED MATERIALS

Cell death in the gut epithelium and implications for chronic inflammation

(2020) Jay V. Patankar et al.   Nature Reviews Gastroenterology & Hepatology

Mucus barrier, mucins and gut microbiota: the expected slimy partners?

(2020) Paola Paone et al.   GUT

At the Forefront of the Mucosal Barrier: The Role of Macrophages in the Intestine

(2020) Barbara Ruder et al.   Cells

The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability

(2020) Ida Schoultz et al.   Cells

Cryo-shocked cancer cells for targeted drug delivery and vaccination

(2020) Tianyuan Ci et al.   Science Advances

Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia

(2020) Rupa Banerjee et al.   Lancet Gastroenterology & Hepatology

Anti-inflammatory activity of polysaccharides from Phellinus linteus by regulating the NF-κB translocation in LPS-stimulated RAW264.7 macrophages

(2019) Zhenglu Xie et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Biomimetic Nanotechnology toward Personalized Vaccines

(2019) Jiarong Zhou et al.   ADVANCED MATERIALS

Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers

(2019) Xi-Xi Wu et al.   INFLAMMATION

The permeation of acamprosate is predominantly caused by paracellular diffusion across Caco-2 cell monolayers: A paracellular modelling approach

(2019) Irina E Antonescu et al.   MOLECULAR PHARMACEUTICS

Cancer-Cell-Membrane-Coated Nanoparticles with a Yolk–Shell Structure Augment Cancer Chemotherapy

(2019) Di Nie et al.   NANO LETTERS

Adenosine Triphosphate Release is Required for Toll-Like Receptor-Induced Monocyte/Macrophage Activation, Inflammasome Signaling, Interleukin-1β Production, and the Host Immune Response to Infection

(2018) Albert H. Lee et al.   CRITICAL CARE MEDICINE

Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction

(2018) Joeri Tulkens et al.   GUT